93 related articles for article (PubMed ID: 2882980)
1. The pharmacokinetics of all-trans-retinoic acid and N-(2-hydroxyethyl)retinamide in mice as determined with a sensitive and convenient procedure. Solid-phase extraction and reverse-phase high performance liquid chromatography.
McPhillips DM; Kalin JR; Hill DL
Drug Metab Dispos; 1987; 15(2):207-11. PubMed ID: 2882980
[TBL] [Abstract][Full Text] [Related]
2. Method to determine 4-oxo-retinoic acids, retinoic acids and retinol in serum and cell extracts by liquid chromatography/diode-array detection atmospheric pressure chemical ionisation tandem mass spectrometry.
Rühl R
Rapid Commun Mass Spectrom; 2006; 20(16):2497-504. PubMed ID: 16862622
[TBL] [Abstract][Full Text] [Related]
3. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
4. Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detection.
Wu C; Njar V; Brodie A; Borenstein M; Nnane I
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):203-8. PubMed ID: 15380716
[TBL] [Abstract][Full Text] [Related]
5. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
[TBL] [Abstract][Full Text] [Related]
6. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer.
Goodman GE; Einspahr JG; Alberts DS; Davis TP; Leigh SA; Chen HS; Meyskens FL
Cancer Res; 1982 May; 42(5):2087-91. PubMed ID: 7039822
[TBL] [Abstract][Full Text] [Related]
8. Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl)retinamide in mice after oral doses.
Kalin JR; Wells MJ; Hill DL
Drug Metab Dispos; 1982; 10(4):391-8. PubMed ID: 6126340
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice.
Thompson HJ; Becci PJ; Grubbs CJ; Shealy YF; Stanek EJ; Brown CC; Sporn MB; Moon RC
Cancer Res; 1981 Mar; 41(3):933-6. PubMed ID: 7459880
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissues.
Vratilova J; Frgala T; Maurer BJ; Patrick Reynolds C
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):125-30. PubMed ID: 15261805
[TBL] [Abstract][Full Text] [Related]
11. Identification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.
Tzimas G; Sass JO; Wittfoht W; Elmazar MM; Ehlers K; Nau H
Drug Metab Dispos; 1994; 22(6):928-36. PubMed ID: 7895612
[TBL] [Abstract][Full Text] [Related]
12. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 13-cis-, all-trans-, 13-cis-4-oxo-, and all-trans-4-oxo retinoic acid after intravenous administration in the cynomolgus monkey.
Sandberg JA; Eckhoff C; Nau H; Slikker W
Drug Metab Dispos; 1994; 22(1):154-60. PubMed ID: 8149876
[TBL] [Abstract][Full Text] [Related]
14. Quantitative high-throughput determination of endogenous retinoids in human plasma using triple-stage liquid chromatography/tandem mass spectrometry.
Gundersen TE; Bastani NE; Blomhoff R
Rapid Commun Mass Spectrom; 2007; 21(7):1176-86. PubMed ID: 17330217
[TBL] [Abstract][Full Text] [Related]
15. Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats.
Ferguson SA; Siitonen PH; Cisneros FJ; Gough B; Young JF
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):582-7. PubMed ID: 16700821
[TBL] [Abstract][Full Text] [Related]
16. Effects of phenobarbital, 3-methylcholanthrene, and retinoid pretreatment on disposition of orally administered retinoids in mice.
Kalin JR; Wells MJ; Hill DL
Drug Metab Dispos; 1984; 12(1):63-7. PubMed ID: 6141914
[TBL] [Abstract][Full Text] [Related]
17. Influence of retinoids on growth and metastasis of hamster melanoma in athymic mice.
Schleicher RL; Moon RC; Patel MK; Beattie CW
Cancer Res; 1988 Mar; 48(6):1465-9. PubMed ID: 3345519
[TBL] [Abstract][Full Text] [Related]
18. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice.
Hultin TA; May CM; Moon RC
Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832
[TBL] [Abstract][Full Text] [Related]
19. Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.
Wang CC; Campbell S; Furner RL; Hill DL
Drug Metab Dispos; 1980; 8(1):8-11. PubMed ID: 6102031
[TBL] [Abstract][Full Text] [Related]
20. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
